VX-828

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-828, covering 2025-06-04 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis [Phase 1]